Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

Dianthus Therapeutics, Inc. (DNTH)

Compare
17.86
+1.03
+(6.12%)
At close: April 2 at 4:00:00 PM EDT
16.00
-1.86
(-10.41%)
Pre-Market: 5:09:18 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
6,235
6,235
2,826
6,417
1,476
Operating Expense
108,099
108,099
51,000
36,122
14,562
Operating Income
-101,864
-101,864
-48,174
-29,705
-13,086
Net Non Operating Interest Income Expense
17,365
17,365
4,764
1,145
3
Other Income Expense
-470
-470
-145
84
-26
Pretax Income
-84,969
-84,969
-43,555
-28,476
-13,109
Net Income Common Stockholders
-84,969
-84,969
-43,555
-28,476
-13,109
Diluted NI Available to Com Stockholders
-84,969
-84,969
-43,555
-28,476
-13,109
Basic EPS
7.22
-2.55
-8.45
-1.92
-0.88
Diluted EPS
7.22
-2.55
-8.45
-1.92
-0.88
Basic Average Shares
28,192.05
33,313.85
5,153.71
14,817.70
14,817.70
Diluted Average Shares
28,192.05
33,313.85
5,153.71
14,817.70
14,817.70
Total Operating Income as Reported
-101,864
-101,864
-48,174
-29,705
-13,086
Total Expenses
108,099
108,099
51,000
36,122
14,562
Net Income from Continuing & Discontinued Operation
-84,969
-84,969
-43,555
-28,476
-13,109
Normalized Income
-85,053
-85,053
-43,470
-28,612
-13,083
Interest Income
17,365
17,365
4,764
1,145
3
Net Interest Income
17,365
17,365
4,764
1,145
3
EBIT
-101,864
-101,864
-48,174
-29,705
-13,086
EBITDA
-101,452
-101,452
-47,819
-29,558
-13,086
Reconciled Depreciation
412
412
355
147
--
Net Income from Continuing Operation Net Minority Interest
-84,969
-84,969
-43,555
-28,476
-13,109
Total Unusual Items Excluding Goodwill
84
84
-85
136
-26
Total Unusual Items
84
84
-85
136
-26
Normalized EBITDA
-101,536
-101,536
-47,734
-29,694
-13,060
12/31/2021 - 6/21/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SYRE Spyre Therapeutics, Inc.
15.49
+1.27%
 
ELVN Enliven Therapeutics, Inc.
19.86
+5.19%
 
COGT Cogent Biosciences, Inc.
5.72
-1.21%
 
PHVS Pharvaris N.V.
14.95
+0.81%
 
CGEM Cullinan Therapeutics, Inc.
7.82
+4.27%
 
CNTA Centessa Pharmaceuticals plc
13.70
+3.55%
 
ORKA Oruka Therapeutics, Inc.
9.42
-1.46%
 
NRIX Nurix Therapeutics, Inc.
11.38
+8.69%
 
GLUE Monte Rosa Therapeutics, Inc.
4.4100
-0.45%
 
TRVI Trevi Therapeutics, Inc.
6.28
+4.49%